A team of researchers from the First Hospital of Hebei Medical University in China has uncovered intriguing evidence that could explain why people with Alzheimer’s disease seem less likely to develop colorectal cancer, and vice versa.
Their study, published in the Proceedings of the National Academy of Sciences, provides experimental support for this inverse relationship, offering new insights that could potentially inform future treatments for both conditions.
For some time now, doctors have observed a curious phenomenon: individuals who suffer from Alzheimer’s disease are less likely to develop certain types of cancer, particularly colorectal cancer.
On the flip side, people diagnosed with colorectal cancer appear to have a lower risk of developing Alzheimer’s. While these observations have been noted for years, it was unclear whether this was just a coincidence or if there was a real connection between the two diseases.
To investigate, the researchers conducted a series of experiments on mice. They wanted to see if there was a genuine link between Alzheimer’s and colorectal cancer, or if the observed relationship was merely a chance occurrence.
The experiment involved two groups of mice: one group was given symptoms resembling Alzheimer’s, while the other group served as a control. The researchers then administered drugs to induce colorectal cancer in both groups. The results were striking.
The mice with Alzheimer’s symptoms were significantly less likely to develop colorectal cancer compared to the control group. This suggested that the presence of Alzheimer’s-like symptoms somehow protected the mice from developing cancer in the colon.
To dig deeper into the underlying mechanisms, the researchers performed another experiment involving stool transplants. They transplanted stool from healthy mice into the mice that had Alzheimer’s symptoms and then tried to induce colorectal cancer.
Interestingly, the mice that received the healthy stool were just as likely to develop tumors as the control mice, indicating that something in the gut microbiome might be playing a role in the relationship between Alzheimer’s and colorectal cancer.
The researchers further examined the gut bacteria of the mice and made another important discovery. Mice with Alzheimer’s symptoms had higher levels of a type of bacteria called Prevotella, which belongs to a group of bacteria known as Gram-negative bacteria.
They also found a similar pattern in humans: individuals diagnosed with mild cognitive impairment (a precursor to Alzheimer’s) had higher levels of Prevotella, while people with colorectal cancer had lower levels of this bacteria.
In a follow-up experiment, the researchers fed healthy mice a substance called lipopolysaccharides, which are molecules derived from Prevotella. They observed that these mice began to show signs of cognitive decline, mimicking Alzheimer’s symptoms.
When these same mice were later treated with standard cancer therapies, they developed fewer tumors. This finding led the researchers to propose that lower levels of Prevotella might make mice more susceptible to colon cancer while also making them less prone to cognitive decline.
Overall, this study provides experimental evidence suggesting an inverse relationship between Alzheimer’s disease and colorectal cancer. The researchers believe that their findings could pave the way for new approaches to treating or preventing these conditions.
For instance, understanding how Prevotella and other gut bacteria influence disease processes could lead to the development of therapies that target the gut microbiome, potentially reducing the risk of both Alzheimer’s and colorectal cancer.
While this research is still in its early stages and conducted in mice, it opens up exciting possibilities for future studies. If these findings can be confirmed in humans, they could have significant implications for how we understand and treat both Alzheimer’s and colorectal cancer.
This study serves as a reminder of the complex and interconnected nature of diseases, highlighting the importance of exploring the body’s various systems and their interactions when searching for new treatments.
If you care about brain health, please read studies about vitamin D deficiency linked to Alzheimer’s and vascular dementia, and extra-virgin olive oil could boost brain function.
For more information about brain health, please see recent studies about antioxidants that could help reduce dementia risk, and strawberries could help prevent Alzheimer’s disease.
The research findings can be found in PNAS.
Copyright © 2024 Knowridge Science Report. All rights reserved.
